Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reflex sympathetic dystrophy syndrome

F Kozin

    Current Opinion in Rheumatology
    |March 1, 1994
    PubMed
    Summary
    This summary is machine-generated.

    Reflex sympathetic dystrophy syndrome (RSDS) research is advancing, revealing increased alpha-adrenergic receptor activity post-injury. Phentolamine may offer a specific diagnostic test for this pain condition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The effect of preoperative exercise on total knee replacement outcomes.

    Clinical orthopaedics and related research·1996
    Same author

    Factors affecting unprescribed remedy use among people with self-reported arthritis.

    Arthritis care and research : the official journal of the Arthritis Health Professions Association·1993
    Same author

    Reflex sympathetic dystrophy syndrome: a review.

    Clinical and experimental rheumatology·1992
    Same author

    Genetic analysis of self-associating immunoglobulin G rheumatoid factors from two rheumatoid synovia implicates an antigen-driven response.

    The Journal of experimental medicine·1992
    Same author

    Genetic studies of four highly homologous rheumatoid factor-associated Vk genes in rheumatoid arthritis patients and normal individuals.

    Molecular immunology·1991
    Same author

    Medical and surgical treatment of seronegative spondyloarthropathies.

    Current opinion in rheumatology·1991
    Same journal

    New approaches to the management of cutaneous lupus.

    Current opinion in rheumatology·2026
    Same journal

    "Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

    Current opinion in rheumatology·2026
    Same journal

    Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

    Current opinion in rheumatology·2026
    Same journal

    Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

    Current opinion in rheumatology·2026
    Same journal

    Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

    Current opinion in rheumatology·2026
    Same journal

    Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

    Current opinion in rheumatology·2026
    See all related articles

    Area of Science:

    • Pain research
    • Neurology
    • Pharmacology

    Background:

    • Recent studies show growing interest in reflex sympathetic dystrophy syndrome (RSDS).
    • Progress in understanding RSDS mechanisms has been made.
    • Increased alpha-adrenergic receptor activity in peripheral nerves post-injury is a key finding.

    Discussion:

    • Sympathetic nerve terminal release of alpha-adrenergic agonists can activate nociceptors, causing pain.
    • This mechanism offers a potential explanation for RSDS pathophysiology.
    • Understanding this pathway is crucial for developing targeted therapies.

    Key Insights:

    • Demonstration of increased alpha-adrenergic receptor activity following peripheral nerve injury.
    • Identification of alpha-adrenergic agonists' role in nociceptor activation and pain.

    Related Experiment Videos

  • Phentolamine as a potential diagnostic agent for recognizing RSDS.
  • Outlook:

    • Further research into alpha-adrenergic pathways in neuropathic pain.
    • Development of more specific diagnostic tools for RSDS.
    • Potential for targeted pharmacological interventions based on adrenergic receptor activity.